secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001493152-25-007938
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity Q3 FY25 revenue $3.6M (+21.7% YoY); net loss down 56.7% to $1.32M
----------------------------------------------------------------------------

- Gross margin improved to 76.4% from 72.9% YoY; recurring tech fees 94% of revenue at 81.4% gross profit.
- Recurring Technology Fees rose 21.8% YoY to $3.39M; pure SaaS revenue up 22%.
- SG&A reduced 20.5% to $2.38M from $3.0M; positive cash flow from operations second consecutive quarter, up 114.5% sequentially.
- Net loss per share improved to $0.054 from $0.339 in Q3 FY24.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315225007938/0001493152-25-007938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315225007938/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-007938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer